Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma

Jun Peng, Yi Wang, Haoyue Hu, Lei Wu, Wei Dai, Yehan Zhou, Na Li, Lin Peng, Xuefeng Leng, Xiang Zhuang, Qifeng Wang, Xiang Wang

Open source

DOI
10.1093/oncolo/oyaf315
Published
2025-09-25
Container
The Oncologist
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyaf315,
  title = {Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma},
  author = {Jun Peng and Yi Wang and Haoyue Hu and Lei Wu and Wei Dai and Yehan Zhou and Na Li and Lin Peng and Xuefeng Leng and Xiang Zhuang and Qifeng Wang and Xiang Wang},
  year = {2025},
  journal = {The Oncologist},
  doi = {10.1093/oncolo/oyaf315},
  url = {https://doi.org/10.1093/oncolo/oyaf315}
}

RIS

TY  - JOUR
TI  - Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma
AU  - Jun Peng
AU  - Yi Wang
AU  - Haoyue Hu
AU  - Lei Wu
AU  - Wei Dai
AU  - Yehan Zhou
AU  - Na Li
AU  - Lin Peng
AU  - Xuefeng Leng
AU  - Xiang Zhuang
AU  - Qifeng Wang
AU  - Xiang Wang
PY  - 2025
JO  - The Oncologist
DO  - 10.1093/oncolo/oyaf315
UR  - https://doi.org/10.1093/oncolo/oyaf315
ER  - 

APA

Peng, J., Wang, Y., Hu, H., Wu, L., Dai, W., Zhou, Y., Li, N., Peng, L., Leng, X., Zhuang, X., Wang, Q., & Wang, X. (2025). Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma. The Oncologist. https://doi.org/10.1093/oncolo/oyaf315

Source records